Efficacy of Canakinumab as First-Line Biologic Agent in Adult-Onset Still’s Disease
Arthritis Research & Therapy
doi 10.1186/s13075-019-1843-9
Full Text
Open PDFAbstract
Available in full text
Date
February 13, 2019
Authors
Publisher
Springer Science and Business Media LLC